Search for: "Wyeth Pharmaceuticals, Inc. "
Results 41 - 60
of 517
Sort by Relevance
|
Sort by Date
24 Dec 2015, 8:20 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc., 777 S.E.2d 176 (S.C. 2015). [read post]
11 Dec 2015, 8:53 am
Ortho-McNeil Pharmaceuticals, Inc., 76 F. [read post]
2 Dec 2015, 12:38 pm
Metabolife Int’l, Inc., 401 F.3d 1233, 1241 (11th Cir. 2005) (reversing admission of expert witness’s testimony when the witness conceded a dose-response, but failed to address the dose of the medication needed to cause the claimed harm). [read post]
13 Nov 2015, 4:54 am
Wyeth, Inc., 2012 WL 733846, at *9 (M.D. [read post]
9 Nov 2015, 7:09 am
Wal-Mart Stores, Inc. v. [read post]
8 Oct 2015, 5:00 am
Caraco Pharmaceutical, Inc., 670 F. [read post]
30 Sep 2015, 4:30 am
Sandoz Pharmaceuticals Corp., 172 F. [read post]
29 Sep 2015, 8:41 am
Wyeth Pharmaceuticals, Inc. [read post]
17 Sep 2015, 3:01 pm
Wyeth, Inc., 85 Cal. [read post]
24 Aug 2015, 5:00 am
Wyeth Pharmaceuticals, 797 F. [read post]
15 Aug 2015, 1:03 pm
Wyeth Pharmaceuticals, Inc., was filed in the U.S. [read post]
13 Aug 2015, 10:56 am
Following Wyeth v. [read post]
7 Aug 2015, 11:30 am
Wyeth Labratories, Inc., 719 F. [read post]
6 Jul 2015, 5:00 am
Wyeth Lab, Inc. that if pharmaceutical manufacturer directly markets to consumers, the learned intermediary doctrine does not apply, it was deemed a “revolutionary,” decision. [read post]
25 Jun 2015, 5:00 am
Wyeth, 705 S.E.2d 828 (W. [read post]
18 Jun 2015, 1:00 pm
Zimmer Holdings, Inc. [read post]
15 Jun 2015, 3:57 am
• Prevacid, Dexilant, & Kapidex – manufactured by Takada Pharmaceuticals USA • Protonix – manufactured by Wyeth • AcipHex – manufactured by Eisai Corporation Large pharmaceutical companies responsible for manufacturing and selling PPIs as heartburn medication have not yet responded to the results of the Stanford study. [read post]
26 May 2015, 7:42 am
Claims such as in Mills, which are at loggerheads with FDA criteria for drug development, are precisely those with the most potential for making pharmaceutical manufacturers into “sitting ducks” for litigation, in this instance litigation based on extraneous genetic factors.It may well be that the coming (and to some extent existing) revolution in genetically individualized medical therapy will require changes in how drugs are evaluated, labeled, etc., but this is a… [read post]
21 May 2015, 1:09 pm
Catheter Connections, Inc. v. [read post]
5 May 2015, 12:05 pm
Recently, the Alabama Legislature passed a bill to reverse their state supreme court's decision in Wyeth Inc. v. [read post]
